During the past decade, Luzerner Kantonsspital; Medizinische Onkologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Luzerner Kantonsspital; Medizinische Onkologie" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Luzerner Kantonsspital; Medizinische Onkologie" are "Breast Cancer" (2 trials), "Gastric Cancer" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Urinary Tract Cancer" (1 trials). Many other conditions were trialed in "Luzerner Kantonsspital; Medizinische Onkologie" in a lesser frequency.

Most popular intervention types in "Luzerner Kantonsspital; Medizinische Onkologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (3 trials), "Docetaxel" (3 trials), "Pertuzumab" (3 trials), "Trastuzumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Luzerner Kantonsspital; Medizinische Onkologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Luzerner Kantonsspital; Medizinische Onkologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Luzerner Kantonsspital; Medizinische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Luzerner Kantonsspital; Medizinische Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".